Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Hunan changsha national hi-tech industrial development zone Lin Yulu number 178

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Payment Terms: L/L

    Orlistat (Orlistat) as a function of the central nervous system obesity drug treatment.
    Only applies to the gastrointestinal tract, lipase by inhibiting the gastrointestinal tract, to prevent hydrolysis three acyl glycerin to free fatty acids and single acyl glyceride, reduce mucous membrane lumen to the absorption of dietary fat three acyl (glycerin), to promote fat out of in vitro.
    Lipase enzyme for gastrointestinal necessary to break down fat, this product can be combined with the stomach, pancreatic lipase serine residues, enzyme inactivation, fat in the food can not be broken down into free fatty acid, inhibit fat utilization and absorption, in addition, this product can be reduce the risk factors associated with obesity.

Send your message to this supplier
  • From:
  • To:
    CHANGYI CITY FENGRUN FINE CHEMICAL CO.,LTD
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service